Overview
Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder
Status:
Active, not recruiting
Active, not recruiting
Trial end date:
2021-08-01
2021-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is for patients who have idiopathic overactive bladder symptoms. This study will evaluate efficacy and safety of Neuronox® against placebo.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Medy-ToxTreatments:
Botulinum Toxins, Type A
Criteria
Inclusion Criteria:- Male and female subjects aged above 20
- Patient with overactive bladder symptoms lasting at least 6 months
Exclusion Criteria:
- Patient with a history of surgery or a disease that may affect bladder function.